Health Management

Philadelphia has the purest and cheapest heroin in the country and a long history of multigenerational heroin addicted families. Here’s what Independence Blue Cross is doing about it.

A Wamberg Genomic Advisors’ Cancer Survey has revealing findings from people dealing directly with cancer.

As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.

The ability of an oncology practice to succeed in the OCM varies depending on this key factor, according to Avalere research.

With healthcare being a key issue in the midterm elections, here are 11 things healthcare executives should keep in mind.

The launch of a new connected health platform will aid in management of diseases such as diabetes.

New cancer drugs continue to offer patients hope. Here are eight of them.

This year has been another year full of oncology approvals, proving that the oncology pipeline is robust with first-of-the kind molecules, competitor products for existing agents, and biosimilars.

What these healthcare industry disruptors are, and how they could impact cost and quality of care.

Innovative PBM performance-based pharmacy networks focus on reducing costs and Improving clinical outcomes

What if your healthcare organization could not only create a plan to retain more millennials as employees, but could hook them before they even graduate from school? Here’s how one healthcare system is doing it.

Ochsner Health System’s brings early-stage clinical trials to the Gulf South region.

New cancer developments and research can be challenging to sort through. Here are four misconceptions about cancer that you should know.

In the managed healthcare market, words like logical, predictable, or stable are seldom used anymore. Instead, for healthcare executives, disruption is the norm.

As payers work to avoid costly readmissions, some organizations are experiencing great success by leveraging virtual care communication platforms.

A stepwise approach can be best. Here are seven rules to follow.

A Mayo Clinic study has surprising findings about how controlled substance agreements impact patients on long-term opioid therapy.

An Avalere analysis finds that this factor plays an important role in the era of value-based payment. Find out what it is.

A new Swedish study examined gender differences in rheumatism and other autoimmune diseases. Here are the surprising findings.

A new study has surprising findings about traumatic or stressful life events and the link to developing an autoimmune disease.

Executives from diagnostics, payer, pharma, and patient care companies recently got together to share stakeholder insights on outcomes-based contracting.

Healthcare organizations can improve care and lower costs-across the board-by paying careful attention to the public health issues affecting their communities.

The right strategies can help healthcare organizations go beyond awareness and actively fight stigma when it comes to mental health conditions.

Here’s what’s shaking up the drug launch pricing space. Experts weigh in.

Managed Healthcare Executive asked experts to identify Trump’s top priorities within the plan, and how those priorities could affect managed care.